#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	1700	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2190	150.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1387	1387	C	219	C	134	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2940	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3533	159.9	0	.	n	.	0	T695C	SNP	695	695	T	1184	1184	C	203	C	124	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2940	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3533	159.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1826	1826	A	156	A	112	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2940	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3533	159.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2460	2460	C	159	C	98	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2940	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3533	159.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3086	3086	T	150	T	100	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2940	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3533	159.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2534	2534	A	196	A	124	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2940	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3533	159.9	0	HET	.	.	.	C76CGGGGG,CGGGG	.	76	76	C	565	565	C	207	CGGGGG,CGGGG	75,59	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	130	folP	855	855	100.0	folP.l6.c4.ctg.1	1632	16.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1028	1030	AGC	26;26;25	A;G;C	18;18;19	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	314	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3276	19.1	1	SNP	p	S91F	1	.	.	271	273	TTC	583	585	TTC	32;32;32	T;T;C	20;21;20	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	314	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3276	19.1	1	SNP	p	D95G	0	.	.	283	285	GAC	595	597	GAC	32;32;32	G;A;C	18;18;18	gyrA.WHO_G_01105:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	314	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3276	19.1	1	SNP	p	D95N	0	.	.	283	285	GAC	595	597	GAC	32;32;32	G;A;C	18;18;18	gyrA.WHO_G_01105:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	517	68	mtrR	633	326	93.27	mtrR.l15.c4.ctg.1	728	5.1	0	.	p	.	0	I104T	NONSYN	310	312	ATC	81	83	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	517	68	mtrR	633	326	93.27	mtrR.l15.c4.ctg.1	728	5.1	0	.	p	.	0	Y106H	NONSYN	316	318	TAC	87	89	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	517	68	mtrR	633	326	93.27	mtrR.l15.c4.ctg.1	728	5.1	0	.	p	.	0	F108S	NONSYN	322	324	TTC	93	95	TCC	1;1;1	T;C,T;C	1;0,1;1	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	517	68	mtrR	633	326	93.27	mtrR.l15.c4.ctg.1	728	5.1	0	.	p	.	0	N110T	NONSYN	328	330	AAC	99	101	ACC	1;1;1	A;C,A;C	1;0,1;1	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	517	68	mtrR	633	326	93.27	mtrR.l15.c4.ctg.1	728	5.1	0	.	p	.	0	L112fs	FSHIFT	334	334	C	105	105	C	1	C	1	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	517	68	mtrR	633	345	100.0	mtrR.l15.c4.ctg.2	653	13.3	1	SNP	p	G45D	1	.	.	133	135	GAC	441	443	GAC	24;24;24	G;A;C	15;15;14	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	50	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	646	14.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	268	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2643	19.9	1	SNP	p	D86N	0	.	.	256	258	GAC	438	440	GAC	27;27;27	G;A;C	17;15;18	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	268	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2643	19.9	1	SNP	p	S87R	0	.	.	259	261	AGT	441	443	AGT	27;28;29	A,G;G;T	13,1;16;16	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	268	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2643	19.9	1	SNP	p	S87I	0	.	.	259	261	AGT	441	443	AGT	27;28;29	A,G;G;T	13,1;16;16	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	268	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2643	19.9	1	SNP	p	S87W	0	.	.	259	261	AGT	441	443	AGT	27;28;29	A,G;G;T	13,1;16;16	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	268	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2643	19.9	1	SNP	p	S88P	0	.	.	262	264	TCC	444	446	TCC	30;30;30	T;C;C	21;16;21	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	236	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2466	17.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1503	1505	GGC	12;12;12	G;G;C	7;9;8	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1309	1311	GCA	46;49;50	G;C;A	29;28;30	penA.4.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1312	1314	ATC	50;50;51	A;T;C	32;30;30	penA.4.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1324	1326	GTG	49;49;49	G,C;T;G	30,1;26;29	penA.4.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1324	1326	GTG	49;49;49	G,C;T;G	30,1;26;29	penA.4.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1828	1830	ACC	23;23;22	A;C;C	11;15;12	penA.4.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1882	1884	GCG	19;19;19	G;C;G	14;14;12	penA.4.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1882	1884	GCG	19;19;19	G;C;G	14;14;12	penA.4.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2005	2007	AGC	12;12;12	A;G;C	8;7;8	penA.4.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2014	2016	GGC	11;11;9	G;G;C,G	7;7;5,1	penA.4.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	284	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2294	23.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2032	2034	CCG	10;10;10	C;C;G	6;6;6	penA.4.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	596	100.0	ponA.l15.c4.ctg.1	822	28.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	1932	98.81	ponA.l15.c4.ctg.2	2099	21.9	0	.	p	.	0	V584A	NONSYN	1750	1752	GTT	1884	1886	GCT	6;5;5	G;C,G;T	4;0,1;0	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	1932	98.81	ponA.l15.c4.ctg.2	2099	21.9	0	.	p	.	0	V588G	NONSYN	1762	1764	GTG	1896	1898	GGG	5;5;5	G;G;G	2;0;0	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	1932	98.81	ponA.l15.c4.ctg.2	2099	21.9	0	.	p	.	0	M603K	NONSYN	1807	1809	ATG	1941	1943	AAG	15;15;15	A;A,T;G	11;0,11;11	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	1932	98.81	ponA.l15.c4.ctg.2	2099	21.9	0	.	p	.	0	V607G	NONSYN	1819	1821	GTG	1953	1955	GGG	14;13;13	G,T;G,T;G	11,1;1,10;10	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	1932	98.81	ponA.l15.c4.ctg.2	2099	21.9	0	.	p	.	0	A612G	NONSYN	1834	1836	GCG	1968	1970	GGG	11;11;11	G;G,C;G	9;0,7;8	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	1932	98.81	ponA.l15.c4.ctg.2	2099	21.9	0	.	p	.	0	Q614H	NONSYN	1840	1842	CAG	1974	1976	CAC	11;9;9	C;A;C,G	10;9;0,8	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	1932	98.81	ponA.l15.c4.ctg.2	2099	21.9	0	.	p	.	0	D617A	NONSYN	1849	1851	GAT	1983	1985	GCA	8;5;5	G;C,A;A,T	7;0,4;0,4	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	1932	98.81	ponA.l15.c4.ctg.2	2099	21.9	0	.	p	.	0	R619fs	FSHIFT	1855	1855	C	1989	1989	C	5	C	4	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	517	388	ponA	2397	1932	98.81	ponA.l15.c4.ctg.2	2099	21.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1395	1397	CCG	21;21;21	C,T;C;G	13,1;10;12	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	136	porA	1146	1146	99.56	porA.l15.c17.ctg.1	1793	14.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	464	466	GGC	14;14;14	G;G;C	9;9;9	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	136	porA	1146	1146	99.56	porA.l15.c17.ctg.1	1793	14.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	646	646	C	18	C	9	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	138	porB1b	1035	1035	96.0	porB1b.l15.c4.ctg.1	1461	18.1	0	.	p	.	0	E48G	NONSYN	142	144	GAA	355	357	GGA	16;16;16	G;G;A	10;10;10	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	138	porB1b	1035	1035	96.0	porB1b.l15.c4.ctg.1	1461	18.1	0	.	p	.	0	F135L	NONSYN	403	405	TTT	616	618	CTT	14;14;15	C;T;T	11;11;13	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	138	porB1b	1035	1035	96.0	porB1b.l15.c4.ctg.1	1461	18.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	640	642	GGA	14;14;14	G;G;A	10;12;12	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	138	porB1b	1035	1035	96.0	porB1b.l15.c4.ctg.1	1461	18.1	0	.	p	.	0	G189S	NONSYN	565	567	GGC	778	780	AGC	24;24;24	A;G,T;C	12;14,1;14	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	138	porB1b	1035	1035	96.0	porB1b.l15.c4.ctg.1	1461	18.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	844	844	T	20	T	15	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	138	porB1b	1035	1035	96.0	porB1b.l15.c4.ctg.1	1461	18.1	1	SNP	p	G120K	0	.	.	358	360	GGT	571	573	GGT	17;17;17	G,C;G;T	12,1;11;11	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	138	porB1b	1035	1035	96.0	porB1b.l15.c4.ctg.1	1461	18.1	1	SNP	p	A121N	0	.	.	361	363	GCC	574	576	GCC	17;17;17	G;C;C	12;11;13	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	138	porB1b	1035	1035	96.0	porB1b.l15.c4.ctg.1	1461	18.1	1	SNP	p	A121D	0	.	.	361	363	GCC	574	576	GCC	17;17;17	G;C;C	12;11;13	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	790	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5072	29.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	84	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	994	17.4	1	SNP	p	V57M	1	.	.	169	171	ATG	447	449	ATG	29;31;31	A;T;G	19;21;20	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
